References
E. Katsyuba et al. "Modulating NAD+ metabolism, from bench to bedside." The EMBO Journal, 36 (2017): 2670 - 2683. https://doi.org/10.15252/embj.201797135.
M. Tarragó et al. "A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline.." Cell metabolism, 27 5 (2018): 1081-1095.e10 . https://doi.org/10.1016/j.cmet.2018.03.016.
R. Houtkooper et al. "Exploring the therapeutic space around NAD+." The Journal of Cell Biology, 199 (2012): 205 - 209. https://doi.org/10.1083/jcb.201207019.
B. Poljšak et al. "Healthy Lifestyle Recommendations: Do the Beneficial Effects Originate from NAD+ Amount at the Cellular Level?." Oxidative Medicine and Cellular Longevity, 2020 (2020). https://doi.org/10.1155/2020/8819627.
Sharma, A., Chabloz, S., Lapides, R. A., Roider, E., & Ewald, C. Y. (2023). Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan. Nutrients, 15(2), 445. https://doi.org/10.3390/nu15020445